サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562203

北米の変形性関節症治療：2030年までの市場予測 - 地域分析 - 治療タイプ、適応疾患、エンドユーザー別

North America Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日
ページ情報
英文 107 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
北米の変形性関節症治療：2030年までの市場予測 - 地域分析 - 治療タイプ、適応疾患、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 107 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の変形性関節症治療市場は、2022年に78億7,388万米ドルと評価され、2030年には135億7,980万米ドルに達すると予測され、2022年から2030年までのCAGRは7.1%と推定されます。

より効果的な治療オプションが北米の変形性関節症治療市場を後押し

現在、OAに対する治療法はないです。臨床研究科学者グループは、臨床試験を通じて、OAの進行を止めることができる革新的な治療ターゲットオプションを開発していることを明らかにしています。例えば、2021年11月、LG Chem社は関節炎を治療する次世代新薬の臨床試験の開始を発表しました。さらに、2021年10月、パシラ・バイオサイエンシズ社は、非オピオイド疼痛管理「ZILRETTA」を治療するフレクシオン・セラピューティクス社の買収を発表しました。2017年に承認された同治療薬は、徐放性マイクロスフェア技術を活用したOA膝痛の治療薬として、最初で唯一承認されたものです。

2023年9月、ソレント・セラピューティクス社は「レジニフェラトキシン（RTX）プログラム」の第2相トップライン臨床試験結果が良好であったことを発表しました。この第2相臨床試験は、中等症から重症のOAK患者の疼痛管理に対するRTXの複数の用量群の有効性と安全性を評価する多施設、二重盲検、プラセボ、アクティブ対照試験です。また、Sorrento社は、現在承認されている競合薬であるZilrettaを現在の臨床試験プロトコールに含めることを決定しました。

北米の変形性関節症治療薬市場概要

北米の変形性関節症治療薬市場は、米国、カナダ、メキシコに区分されます。米国食品医薬品局（FDA）による変形性関節症治療薬の迅速な製品上市と、製品上市を促進するための政府支援が、市場成長の最も大きな影響要因です。米国疾病予防管理センター（CDC）の報告書で明らかにされた統計によると、変形性関節症（OA）は最も一般的な関節炎であり、米国の成人3,250万人が罹患しています。また、Osteoarthritis（OA）Action Allianceの報告書によると、米国におけるOAに関連する経済的負担は、全体で年間1,368億米ドルと推定されています。さらに、米国レントゲン光線学会（ARRS）の報告書によると、OAの生涯リスクは50％であり、2040年までに米国成人の7,800万人（26％）がOAに罹患すると推定されています。

さらに、OA疼痛に対する非薬物療法を目指すメーカーによる新製品の承認は、市場成長にさらに影響を与えます。例えば、2021年6月、CyMedica Orthopedics社は、米国食品医薬品局（USFDA）から変形性膝関節症の痛みに対する非侵襲的モダリティである「Intellihab System」の承認を受けたと発表しました。この新製品発表は、衰弱性変形性関節症疾患を伴うOA疼痛を治療するための、治療的かつデジタルベースのエコシステムです。したがって、治療薬への依存を減らすことに焦点を当てたOA疼痛を意図した新しい非薬物療法は、変形性関節症治療市場の成長を促進するための重要な要因です。

北米の変形性関節症治療市場の収益と2030年までの予測（金額）

北米の変形性関節症治療市場のセグメンテーション

北米の変形性関節症治療市場は、治療タイプ、適応疾患、エンドユーザー、国に分類されます。

治療タイプ別に見ると、北米の変形性関節症治療市場は、経皮的電気神経刺激（TENS）、作業療法、理学療法、多血小板血漿（PRP）療法＆間質血管分画、プロロセラピー、その他に区分されます。理学療法分野が2022年に最大の市場シェアを占めました。

疾患適応症の観点から、北米の変形性関節症治療市場は変形性膝関節症、変形性脊椎関節症、変形性足関節症、変形性肩関節症、変形性手関節症、その他に区分されます。変形性膝関節症セグメントは、2022年の北米の変形性関節症治療市場で最大のシェアを占めました。

エンドユーザー別に見ると、北米の変形性関節症治療市場は、病院・クリニック、専門クリニック、外来手術センター、在宅ケア、その他に分類されます。2022年の北米の変形性関節症治療市場は、在宅ケア分野が最大シェアを占めました。

国別では、北米の変形性関節症治療市場は米国、カナダ、メキシコに区分されます。2022年の北米の変形性関節症治療市場シェアは米国が独占しました。

Vision Quest Industries Inc、Dr PRP USA LLC、Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc、Medi GmbH &Co KGは、北米の変形性関節症治療市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 変形性関節症治療市場情勢

  • パイプライン分析
    • 臨床試験パイプライン分析

第5章 北米の変形性関節症治療市場：主要市場力学

  • 市場促進要因
    • 変形性関節症の有病率の上昇
    • 革新的な治療オプションによる薬物依存の軽減
  • 市場抑制要因
    • 製品回収
  • 市場機会
    • 再生医療の利用可能性
  • 今後の動向
    • より効果的な治療オプション
  • 促進要因と抑制要因の影響

第6章 変形性関節症治療市場：北米市場分析

    • 変形性関節症治療市場収益、2020-2030年

第7章 北米の変形性関節症治療市場分析：治療タイプ別

  • 経皮的電気神経刺激療法（TENS）
  • 作業療法
  • 理学療法
  • 多血小板血漿療法と間質血管分画療法
  • プロロセラピー
  • その他

第8章 北米の変形性関節症治療市場分析：適応疾患別

  • 変形性膝関節症
  • 脊椎変形性関節症
  • 変形性足関節症
  • 肩変形性関節症
  • 手の変形性関節症
  • その他

第9章 北米の変形性関節症治療市場分析：エンドユーザー別

  • 病院およびクリニック
  • 専門クリニック
  • 外来手術センター
  • 在宅医療
  • その他

第10章 北米の変形性関節症治療市場：国別分析

  • 北米市場概要
    • 北米
      • 米国
      • カナダ
      • メキシコ

第11章 業界情勢

  • 変形性関節症治療市場における成長戦略
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • Vision Quest Industries Inc
  • Dr PRP USA LLC
  • Zimmer Biomet Holdings Inc
  • DePuy Synthes Inc
  • Bioventus Inc
  • Omron Healthcare Inc
  • Exactech Inc
  • Medi GmbH & Co KG

第13章 付録

図表

List Of Tables

  • Table 1. Osteoarthritis Therapy Market Segmentation
  • Table 2. Ongoing Clinical Trial of Osteoarthritis
  • Table 3. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 4. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 5. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 6. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 7. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 8. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 10. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 11. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 12. Organic Developments Done by Companies
  • Table 13. Inorganic Developments Done by Companies

List Of Figures

  • Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
  • Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
  • Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
  • Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
  • Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America: Osteoarthritis Therapy Market by Key Countries - Revenue (2022) US$ Million
  • Figure 26. North America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Growth Strategies in the Osteoarthritis Therapy market
目次
Product Code: BMIRE00030514

The North America osteoarthritis therapy market was valued at US$ 7,873.88 million in 2022 and is expected to reach US$ 13,579.80 million by 2030; it is estimated to register a CAGR of 7.1% from 2022 to 2030.

More Effective Treatment Options Fuels North America Osteoarthritis Therapy Market

Currently, there is no cure for OA. A group of clinical research scientists, through clinical trials, reveal that they are developing innovative treatment target options that can stop the progression of OA. For example, in November 2021, LG Chem company announced the initiation of a clinical trial for next-generation new drugs to treat arthritis. Additionally, in October 2021, Pacira BioSciences, Inc. announced the acquisition of Flexion Therapeutics to treat non-opioid pain management "ZILRETTA". The drug approved in 2017 is the first and only approved treatment for OA knee pain utilizing extended-release microsphere technology.

In September 2023, Sorrento Therapeutics, Inc. announced positive Phase 2 top-line clinical trial results for the "Resiniferatoxin (RTX) program". The Phase 2 trial is a multi-center, double-blind, placebo, and active-controlled study assessing the efficacy and safety of several dose groups of RTX to manage pain in patients with moderate-to-severe OAK. Also, Sorrento decided to include an active approved competitor drug, "Zilretta," in the current clinical trial protocol.

North America Osteoarthritis Therapy Market Overview

North America osteoarthritis therapy market is segmented as US, Canada, and Mexico. Fast product launches by the US Food and Drug Administration (FDA) for osteoarthritis drugs and government support for accelerating product launches are the most impacting factors for the market growth. According to the statistics revealed in the Centers for Disease Control and Prevention (CDC) report, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million US adults. Additionally, the Osteoarthritis (OA) Action Alliance report reveals that the overall economic burden associated with OA in the US is estimated at US$ 136.8 billion annually. Further, the American Roentgen Ray Society ARRS report reveals that the lifetime risk of OA is 50%, and it is estimated that by 2040, ~78 million (26%) US adults will have OA.

Further, new product approvals by the manufacturers aiming for non-pharmacology therapy for OA pain further influence market growth. For instance, in June 2021, CyMedica Orthopedics announced receiving approval for the "Intellihab System," a noninvasive modality for knee osteoarthritis pain by the US Food and Drug Administration (USFDA). The new product launch is a therapeutic and digital-based ecosystem that is designed to treat OA pain with a debilitating osteoarthritis disease. Therefore, new non-pharmacology therapy intended for OA pain focusing on reducing dependency on therapeutics is a key factor for fueling the growth of the osteoarthritis therapy market.

North America Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

North America Osteoarthritis Therapy Market Segmentation

The North America osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the North America osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the North America osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of North America osteoarthritis therapy market in 2022.

Based on end user, the North America osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of North America osteoarthritis therapy market in 2022.

By country, the North America osteoarthritis therapy market is segmented into the US, Canada, and Mexico. The US dominated the North America osteoarthritis therapy market share in 2022.

Vision Quest Industries Inc, Dr PRP USA LLC, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, and Medi GmbH & Co KG are some of the leading companies operating in the North America osteoarthritis therapy market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

  • 4.1 Pipeline Analysis
    • 4.1.1 Clinical Trial Pipeline Analysis

5. North America Osteoarthritis Therapy Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Osteoarthritis
    • 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
  • 5.2 Market Restraints
    • 5.2.1 Product Recall
  • 5.3 Market Opportunities
    • 5.3.1 Availability of Regenerative Medicine
  • 5.4 Future Trends
    • 5.4.1 More Effective Treatment Options
  • 5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - North America Market Analysis

  • 6.1 Overview
    • 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. North America Osteoarthritis Therapy Market Analysis - by Therapy Type

  • 7.1 Overview
  • 7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
    • 7.2.1 Overview
    • 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Occupational Therapy
    • 7.3.1 Overview
    • 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Physical Therapy
    • 7.4.1 Overview
    • 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
    • 7.5.1 Overview
    • 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Prolotherapy
    • 7.6.1 Overview
    • 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Osteoarthritis Therapy Market Analysis - by Disease Indication

  • 8.1 Overview
  • 8.2 Knee Osteoarthritis
    • 8.2.1 Overview
    • 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Spine Osteoarthritis
    • 8.3.1 Overview
    • 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Foot and Ankle Osteoarthritis
    • 8.4.1 Overview
    • 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Shoulder Osteoarthritis
    • 8.5.1 Overview
    • 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Hand Osteoarthritis
    • 8.6.1 Overview
    • 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Osteoarthritis Therapy Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
    • 9.2.1 Overview
    • 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Specialty Clinics
    • 9.3.1 Overview
    • 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Homecare
    • 9.5.1 Overview
    • 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Osteoarthritis Therapy Market - Country Analysis

  • 10.1 North America Market Overview
    • 10.1.1 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.3 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the osteoarthritis therapy market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Vision Quest Industries Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Dr PRP USA LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Zimmer Biomet Holdings Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 DePuy Synthes Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Bioventus Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Omron Healthcare Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Exactech Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medi GmbH & Co KG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners